使用机器学习在危重病患者中对脂质体安二B对功能影响的真实世界数据观察分析
Ignasi Sacanella1, Erika Esteve-Pitarch1, Jessica Guevara-Chaux2,3
1Department of Pharmacy, Hospital Universitari Joan XXIII, 43005 Tarragona, Spain.
Antibiotics (Basel, Switzerland)
|August 29, 2024
概括
在重症患者中使用脂质体安福特 B (L-AmB) 并没有显示急性损伤 (AKI) 的增加. L-AmB似乎是安全的,AKI的发展是多因素的.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學.
- 关键护理医学 关键护理医学
- 传染性疾病 传染性疾病
背景情况:
- 脂质体安二乙 (L-AmB) 是对严重的侵入性真菌感染的主要治疗方法.
- 对L-AmB的潜在毒性需要仔细监测.
研究的目的:
- 在接受L-AmB超过48小时的重症患者中评估急性损伤 (AKI) 的发生率.
- 确定在这个患者队列中促进AKI发展的因素.
主要方法:
- 回顾性,观察性,单中心研究设计.
- 从电子医疗记录中提取的数据,包括临床,人口和实验室变量.
- 在总人口中分析了AKI发病率,并根据基线肌素风险 (低/高) 分层.
- 采用随机森林模型来确定与AKI相关的因素.
主要成果:
- 包括67名重症患者 (平均年龄61岁,67%男性,中位数SOFA4).
- 整体的AKI发病率为26.8% (低风险:25%,高风险:13%).
- 没有观察到有意义的血清肌素变化,高风险亚组的血清肌素减少.
- 诺拉上腺素,SOFA评分,化物,,C反应蛋白,和公素被确定为AKI贡献者.
结论:
- 在接受L-AmB的患者中,急性损伤的发展是多因素的.
- 在关键病情患者中,L-AmB的使用似乎是安全的,因为它对脏有毒性.
更多相关视频
04:09Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
Published on: October 10, 2018
8.2K
07:15Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model
Published on: August 16, 2020
6.8K
相关概念视频
Factors Affecting Renal Clearance: Renal Impairment
62
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
62
Renal Failure: Dose Adjustments
69
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
69
